BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21126027)

  • 1. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent.
    Shetty RS; Lee Y; Liu B; Husain A; Joseph RW; Lu Y; Nelson D; Mihelcic J; Chao W; Moffett KK; Schumacher A; Flubacher D; Stojanovic A; Bukhtiyarova M; Williams K; Lee KJ; Ochman AR; Saporito MS; Moore WR; Flynn GA; Dorsey BD; Springman EB; Fujimoto T; Kelly MJ
    J Med Chem; 2011 Jan; 54(1):179-200. PubMed ID: 21126027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities.
    Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ
    ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
    Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
    J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
    Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities.
    Keller L; Beaumont S; Liu JM; Thoret S; Bignon JS; Wdzieczak-Bakala J; Dauban P; Dodd RH
    J Med Chem; 2008 Jun; 51(12):3414-21. PubMed ID: 18503262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
    La Regina G; Edler MC; Brancale A; Kandil S; Coluccia A; Piscitelli F; Hamel E; De Martino G; Matesanz R; Díaz JF; Scovassi AI; Prosperi E; Lavecchia A; Novellino E; Artico M; Silvestri R
    J Med Chem; 2007 Jun; 50(12):2865-74. PubMed ID: 17497841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
    Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
    J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of anti-microtubule N-(2-Arylindol-7-yl)benzenesulfonamide derivatives and their antitumor mechanisms.
    Chiou CT; Chen GS; Chen ML; Li H; Shi L; Huang XH; Dai WM; Chern JW
    ChemMedChem; 2010 Sep; 5(9):1489-97. PubMed ID: 20672297
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents.
    Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP
    Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
    Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
    ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
    De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
    J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
    Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
    J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.
    Lee J; Kim SJ; Choi H; Kim YH; Lim IT; Yang HM; Lee CS; Kang HR; Ahn SK; Moon SK; Kim DH; Lee S; Choi NS; Lee KJ
    J Med Chem; 2010 Sep; 53(17):6337-54. PubMed ID: 20690624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
    Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.
    Zhao DG; Chen J; Du YR; Ma YY; Chen YX; Gao K; Hu BR
    J Med Chem; 2013 Feb; 56(4):1467-77. PubMed ID: 23360369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
    Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
    J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.